Scully M F, Weerasinghe K M, Ellis V, Djazaeri B, Kakkar V V
Thromb Res. 1983 Jul 1;31(1):87-97. doi: 10.1016/0049-3848(83)90010-5.
Pentosan polysulphate (PPS, Hemoclar, MW 6,700) was observed to have a low affinity for ATIII-Sepharose eluting at 0.3M NaCl. Tested in vitro it had, as previously reported, a low potency as an anticoagulant, about 10 times less than heparin on a weight for weight basis. Only the KCCT was affected by low concentrations of PPS unlike heparin by which both thrombin time and KCCT were affected. Upon injection of PPS subcutaneously (50mg) the heparin activity measured by chromogenic anti factor Xa and by KCCT was in the ratio of 2:1. When injected intravenously (40mg) into 3 healthy volunteers a significant prolongation of a modified prothrombin time was observed in 2 subjects. When PPS was added to heparin containing plasma it was observed to completely inhibit heparin at low concentrations (2:1 on a weight to weight basis) when measured in the thrombin and prothrombin time but not in the KCCT. The antiheparin effect of PPS was also observed in a purified system in obviating the heparin potentiation of the rate of inhibition of thrombin by antithrombin III. Observations showed that at higher concentrations of PPS it acted by directly inhibiting thrombin without the intervention of antithrombin III but also to potentiate the rate of fibrin monomer polymerization.
戊聚糖多硫酸盐(PPS,Hemoclar,分子量6700)在0.3M氯化钠条件下从抗凝血酶III - 琼脂糖柱上洗脱,显示其与抗凝血酶III - 琼脂糖的亲和力较低。如先前报道,体外测试显示其作为抗凝剂的效力较低,按重量计算约为肝素的十分之一。与肝素不同,只有白陶土部分凝血活酶时间(KCCT)受低浓度PPS影响,而肝素会同时影响凝血酶时间和KCCT。皮下注射PPS(50mg)后,通过发色底物法测定抗Xa因子活性和KCCT法测得的肝素活性之比为2:1。静脉注射(40mg)给3名健康志愿者后,2名受试者的改良凝血酶原时间显著延长。当将PPS添加到含肝素的血浆中时,在凝血酶时间和凝血酶原时间测定中,低浓度(重量比为2:1)的PPS能完全抑制肝素,但在KCCT测定中则不然。在纯化系统中也观察到PPS的抗肝素作用,即消除抗凝血酶III对凝血酶抑制速率的肝素增强作用。观察表明,在较高浓度的PPS下,它可直接抑制凝血酶,无需抗凝血酶III的干预,而且还能增强纤维蛋白单体聚合速率。